EligibleTrials

Clinical trials recruiting for Sarcoma,Soft Tissue

Fewer than 3 recruiting trials found.

2
Recruiting trials
1
US states with sites
2
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 2Phase 2 1

Drugs and treatments being studied

InterventionTrials
Aldesleukin1
CYCLOPHOSPHAMIDE and FLUDARABIN1
Cohort A: Extensive Stage Small Cell Lung Cancer (ES-SCLC) Thoracic Tumor PULSAR (Personalized ultrahypofractionated stereotactic ablative radiotherapy)1
Cohort B: Brain metastasis PULSAR (Personalized ultrahypofractionated stereotactic ablative radiotherapy)1
Cohort C: Sarcoma Pre-Operative PULSAR1
Cohort D: Resectable Head & Neck Squamous Cell Carcinoma (HNSCC) PULSAR/SAbR1
Cyclophosphamide1
HBI 0201-ESO TCRT1

Where trials are recruiting (top US states)

StateRecruiting trials
Texas1

Top cities

Dallas, Texas 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Sarcoma,Soft Tissue often also study these conditions. Each links to its own recruiting-trial list.

Lung cancer 2180Triple-negative breast cancer 138Thoracic Cancer 9Solid Tumor, Adult 38Small Cell Lung Cancer Extensive Stage 14Ovary Cancer 4Non-small cell lung cancer 507Metastatic Cancer 31Melanoma Stage IV 23Melanoma 487

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Sarcoma,Soft Tissue trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.